RSPI RespireRx Pharmaceuticals Dashboard

Cannabinoids is a broad term to describe the pharmacologically active naturally occurring substances found within the cannabis (marijuana) plant. While the liberalization of state laws regulating the use and sales of marijuana has created a major industry based on the commercialization of marijuana for both medical and recreational use, the U.S. Food and Drug Administration (“FDA”) has not recognized or approved the marijuana plant as medicine nor is it federally legal to sell products that contain cannabinoids as drugs, dietary supplements or foods (edibles) without its approval. From a scientific and pharmaceutical perspective, however, we do not think that pharmaceutical cannabinoids should suffer from the stigma that marijuana has, since it was declared a controlled substance in the 1930’s. We believe that cannabinoids should be considered pharmaceuticals developed under FDA and comparable international regulatory bodies that happen to have been originally derived from plants much like aspirin, theophylline or tamoxifen.

Company profile

Ticker

RSPI

Exchange

OTC

Website

www.respirerx.com

CEO

Arnold S. Lippa

Incorporated

Delaware

Location

New Jersey

Fiscal year end

Dec 31

Sector

Health Technology > Pharmaceuticals

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co • Allergan • Abbott Laboratories • Teva- Pharmaceutical Industries • Lilly(Eli) & Co • Bristol-Myers Squibb • Viatris • Warner Chilcott ...

Former names

CORTEX PHARMACEUTICALS INC/DE/

SEC CIK

0000849636

Corporate docs

Articles of Incorporation & Bylaws

IRS number

330303583

RSPI stock data

S&P 500

1M 1Y 2Y 5Y

Press releases

Pro users get this 30m faster

RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference

8 Jun 21

Glen Rock, N.J., June 08, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB Market: RSPI) ("RespireRx" or the "Company"), a leader in the discovery and development of innovative and revolutionary

RespireRx Pharmaceuticals Inc. Announces New Data Regarding the Use of AMPAkines as Potential Treatments for Spinal Cord Injury

12 May 21

Glen Rock, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB:RSPI) ("RespireRx" or the "Company"), a leader in the discovery and development of innovative and revolutionary treatments to

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

24 May 21

2 Aug 21

31 Dec 21

Financial summary

Financial statements Chart RSPI financial data

Quarter (USD)	Mar 21	Dec 20	Sep 20	Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	5.35K	5.35K	5.35K	5.35K	5.35K	5.35K
Cash burn (monthly)	(positive/no burn)	(positive/no burn)	266.71K	299.56K	95.62K	(positive/no burn)
Cash used (since last report)	n/a	n/a	1.09M	1.23M	391.84K	n/a
Cash remaining	n/a	n/a	-1.09M	-1.22M	-386.5K	n/a
Runway (months of cash)	n/a	n/a	-4.1	-4.1	-4.0	n/a

Beta Read what these cash burn values mean

Recent insider trades

RSPI insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
30 Sep 20	Jeff Eliot Margolis	Common Stock	Conversion	Aquire C	Yes	No	0	5,017,144	0	5,142,351
30 Sep 20	Jeff Eliot Margolis	Common Stock	Conversion	Aquire C	Yes	No	0	5,017,144	0	5,142,351
30 Sep 20	Jeff Eliot Margolis	Common Stock	Conversion	Aquire C	Yes	No	0	91,871,094	0	96,151,863
30 Sep 20	Jeff Eliot Margolis	Warrants (to purchase Common Stock) Common Stock	Conversion	Aquire C	Yes	No	0.007	5,017,144	35.12K	5,017,144
30 Sep 20	Jeff Eliot Margolis	Warrants (to purchase Common Stock) Common Stock	Conversion	Aquire C	Yes	No	0.007	5,017,144	35.12K	5,017,144
30 Sep 20	Jeff Eliot Margolis	Warrants (to purchase Common Stock) Common Stock	Conversion	Aquire C	Yes	No	0.007	91,871,094	643.1K	91,871,094
30 Sep 20	Jeff Eliot Margolis	Series H Preferred Stock Conversion Units	Gift	Aquire G	Yes	No	0.0064	7	0.04	32.11
30 Sep 20	Jeff Eliot Margolis	Series H Preferred Stock Conversion Units	Gift	Dispose G	No	No	0.0064	7	0.04	0
30 Sep 20	Jeff Eliot Margolis	Series H Preferred Stock Conversion Units	Gift	Aquire G	Yes	No	0.0064	7	0.04	32.11
30 Sep 20	Jeff Eliot Margolis	Series H Preferred Stock Conversion Units	Gift	Dispose G	No	No	0.0064	7	0.04	7

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q1 2021

RSPI institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders	Current	Prev Q	Change
Total holders	0	0
Opened positions	0	0
Closed positions	0	0
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	0	0
Total shares	0	0
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change

Largest transactions	Shares	Bought/sold	Change

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Management Discussion

The Company’s consolidated statements of operations as discussed herein are presented below.

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Bad

New words: broader, broker, chart, clause, contractor, debited, Entrepreneurship, fifteen, fractional, Hedging, incremental, interaction, merged, modest, nearest, NJ, partial, printer, proportionately, repay, rounded, Sheriff, sickle, Topic, Writ, WT, WTs, yearly

Removed: AASM, absence, absorption, abuse, Academy, accept, accident, accredited, achieve, achieved, achieving, acid, activation, actively, acute, addressed, adequately, adjacent, adjust, administration, adult, advanced, adverse, advocacy, afford, AHI, AIH, air, airflow, airway, alcohol, alprazolam, alteration, altering, alternate, alternative, ameliorating, America, American, Amid, amortization, AMPA, amphetamine, amplify, analgesia, analgesic, analogue, analyzing, announced, anorexia, antagonism, antagonizing, anticonvulsant, antiepileptic, anxiety, applicant, appointment, approximating, arisen, arising, artery, Article, ASC, ascribed, assay, assessing, assessment, assignment, assist, assuming, assured, atomoxetine, attach, attaining, attempt, attempted, attenuate, attenuated, automatically, automobile, avoid, aware, BDZ, bearing, beneficially, bid, bilaterally, bind, binding, Black, blinded, blood, blowing, body, brain, brainstem, breakthrough, breath, breathe, brokerage, burden, burgeoning, calculated, call, called, cancer, cannabidiol, Cannabimimetic, capsule, cardiac, cardinal, cardiovascular, care, Carley, CBD, cellular, central, cessation, channel, characterized, chemical, chemistry, Chicago, children, chloride, circuitry, claiming, clarification, clearance, clinically, closing, cocaine, Codification, cognition, cognitive, collection, combination, combined, commonly, communicate, comply, compromised, concept, concurrent, conduct, conducting, confession, confirmatory, confirmed, congestive, considerable, constituted, consultation, consummate, consummated, contrast, controlled, convulsive, Cook, coronary, Cosmetic, costly, cover, coverage, CPAP, create, creation, crossover, cumbersome, CVS, daily, database, daytime, decided, decreased, defer, degree, dehydrated, delivery, demonstrate, demonstrated, demonstrating, demonstration, dental, depending, depository, desirable, desired, detailed, deteriorated, device, diagnose, diagnosed, diagnosing, diagnostic, dialogue, diazepam, dietary, differentiated, diligence, direction, Directive, disability, disclosing, discomfort, discover, discrimination, dismissal, display, displaying, distribution, diversion, door, dramatically, drawdown, druggable, dry, duration, eating, economically, efficient, effort, electrical, emerged, emergency, emphasized, employee, enabling, encourage, ending, enduring, enhance, enhanced, enhancement, enhancing, enter, entitled, epidemic, Epidiolex, epileptic, epileptiform, Epworth, equal, erratic, escalation, escrow, establish, establishment, Europe, European, evaluable, evidencing, excessive, excised, excitability, excitatory, excluding, exclusivity, exhibit, existing, expand, expanding, expensive, expertise, export, extensive, extensively, face, factor, failure, faith, family, fashion, faster, feedback, feel, field, finalize, FirstFire, FIT, Fitbit, Florida, focused, food, forgave, formulated, found, framework, France, frequency, frequently, freshly, friendly, Fuller, fundamental, funded, funding, GABA, GABAergic, gabapentin, gained, gave, gel, gelatin, generic, genetic, gentler, Germany, glaucoma, global, globally, glycol, good, governmental, greater, greatest, greatly, group, growth, guaranty, halt, hand, headed, HealthHUB, heart, hemisected, heterogeneity, higher, highlighted, highlighting, highly, home, hope, hybrid, hypertension, hypoglossal, hypopnea, hypoxia, hypoxic, idea, ideation, identification, identify, impair, impaired, impairment, implantable, implanted, implementation, implementing, import, important, Importantly, improve, improved, impulsivity, inattention, incoordination, incorporated, increasing, IND, indiscriminately, induce, induced, inducing, industry, inflammation, infringe, inhibition, inhibitory, initiate, initiated, insert, Institute, insufficient, intact, integral, intent, intention, intermittent, intermittently, interpreted, intimately, intrinsic, invasive, involved, ion, Jeffrey, Junior, key, kinder, kindling, Kingdom, labelled, laboratory, lack, large, lead, leading, learn, lease, led, lend, Lender, lending, lethality, liberalization, licensure, limit, liquid, liquidation, literature, live, liver, living, loaned, locomotor, logistical, Lung, Lyrica, maintained, making, manage, manipulation, marijuana, Marinol, marketable, marketed, masked, maximal, mechanism, mechanistic, mediate, medical, medically, medicine, meeting, men, merger, metabolism, metabolized, mg, mice, microelectrode, midazolam, million, moderate, modulating, monoaminergic, morbidity, morning, mortality, motor, mouth, multiple, muscle, muscular, nano, national, nationwide, nausea, negatively, nerve, network, neural, neurobehavioral, neurocognitive, neuromodulation, neuron, Neurontin, neuropharmacological, neurotransmission, neurotransmitter, night, NIH, Northwestern, nose, notification, notified, notify, NW, NYSE, obesity, objective, observed, occurring, offer, OIRD, onset, opened, opioid, opportunity, opposed, optimally, optimized, oral, ordinary, oriented, orphan, overdose, overwhelming, PACE, package, PAM, panel, paradigm, paralleled, participating, party, path, pathway, paying, percent, percentage, perception, permission, pharmacokinetic, pharmacological, pharmacologically, Pharmacotherapy, pharyngeal, pivotal, placebo, plant, plasticity, polyethylene, polypharmacy, poorly, Power, practice, preceding, predecessor, preference, pregabalin, presently, pressure, pressurized, prevalent, primary, primate, principle, priority, problem, procedure, proceed, processing, produce, produced, producing, production, profile, profoundly, Project, promising, prompted, promulgated, proof, properly, propose, protection, protein, protocol, proven, provisional, provocation, published, purified, pursue, put, question, randomized, rapid, rapidity, rapidly, Rating, reaching, receiving, recent, receptor, recordation, recreational, reduced, reduction, refuse, regaining, regulated, regulating, reimbursement, relationship, relax, relaxation, relevant, reliably, rely, remarkably, remote, removal, renewed, repaid, repeated, repetitive, replicated, requesting, require, requiring, resection, reserved, residing, resignation, response, responsible, restate, restoration, review, revised, road, rodent, role, room, roughly, route, Rule, salary, salivation, Samyang, Sativex, Saturday, scale, scheduled, school, score, secondary, secretion, securing, sedation, seek, seizure, selective, selectively, selectivity, sell, sensation, sensitization, separable, serve, served, serving, sesame, shipping, shown, side, significantly, Similarly, site, small, smart, Society, soft, soluble, solution, somnolence, spasticity, specific, specificity, spinning, statistically, step, stimulant, stimulate, stimulation, stimulator, store, strategic, Strattera, strength, stroke, strong, structural, study, submission, substitute, subtype, subunit, successfully, successive, suffer, suggesting, suicidal, suited, sum, supporting, suppressed, surgery, surgical, surprising, synaptic, synthesized, tail, target, targeting, tested, therapeutically, therapy, thin, throat, tissue, tolerance, tolerate, tolerated, tone, tongue, tooth, tracking, trading, traditional, traffic, transferred, translational, transmission, transportation, treat, treated, treating, turned, twenty, type, UIC, ultimately, uncontrolled, undergo, underlie, underserved, underway, undesirable, undiagnosed, undisputed, unique, unissued, unit, unmet, unnecessary, unresponsive, unsuccessful, untreated, upper, Valium, variable, variety, varying, version, vivo, vomiting, voting, walking, watch, water, week, weight, wide, widely, wider, window, withdrawal, Witkin, women, worked, writing, written, young

From filing 10-Q 2021 Q1